Cite
HARVARD Citation
Le, B. et al. (2022). Oxycodone/naloxone prolonged‐release tablets in patients with moderate‐to‐severe, chronic cancer pain: Challenges in the context of hepatic impairment. Asia-Pacific journal of clinical oncology. 18 (1), pp. 13-18. [Online].